Evaluation of genetic diversity of human immunodeficiency virus type 1 nef gene associated with vertical transmission

Journal of Biomedical Science

Volumn 10, Issue 4, 2003, Pages 436-450

  Hahn, Tobias ^a   Ramakrishnan, Rajesh ^a   Ahmad, Nafees ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Genetic diversity; HIV 1; nef; Vertical transmission

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; EVOLUTION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC DISTANCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; MEMBRANE BINDING; MOTHER FETUS RELATIONSHIP; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PERINATAL INFECTION; PHYLOGENY; POPULATION GROWTH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; TWINS; VERTICAL TRANSMISSION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE PRODUCTS, NEF; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MATERNAL-FETAL EXCHANGE; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; PREGNANCY; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0038646275     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000071163     Document Type: Article

References (72)

1. Ahmad N. Maternal-fetal transmission of human immunodeficiency virus. J Biomed Sci 3:238-250;1996.
2. Ahmad N. Molecular mechanisms of human immunodeficiency virus type 1 mother-infant transmission. Adv Pharmacol 49:387-415;2000.
3. Ahmad N, Baroudy BM, Baker RC, Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 69:1001-1012;1995.
4. Ahmad N, Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481-1485:1985.
5. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864;1994.
6. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Contrib 19: 716-723;1974.
7. Akari H, Arold S, Fukumori T, Okazaki T, Strebel K, Adachi A. Nef-induced major histo-compatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J Virol 74:2907-2912;2000.
8. Aldrovandi GM, Gao L, Bristol G, Zack JA. Regions of human immunodeficiency virus type 1 nef required for function in vivo. J Virol 72:7032-7039;1998.
9. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, Ruprecht RM. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 5:194-203;1999.
10. Baur AS, Sass G, Laffert B, Willbold D, Cheng-Mayer C, Peterlin BM. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6:283-291;1997.
11. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 8:1235-1238;1998.
12. Centers for Disease Control and Prevention Classification system for human immunodeficiency virus (HIV) in children under 13 years of age. MMWR Morb Mortal Wkly Rep 36:225-236;1987.
13. Cheng-Mayer C, Lannello P, Shaw K, Luciw PA, Levy JA. Differential effects of nef on HIV replication: Implication for viral pathogenesis in the host. Science 246:1629-1632;1989.
14. Colgrove RC, Pitt J, Chung PH, Wells SL, Japour AJ. Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 12:2281-2288;1998.
15. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401;1998.
16. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford M, Hooker M, McPhee DA, Greenway AL, Ellet A, Chatfield C, et al. Genomic structure of an attenuated quasi species of HIV-1 from blood transfusion donor recipients. Science 270:988-991;1995.
17. Dickover RE, Garratty EM, Plaeger S, Bryson YJ. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intra-partum. J Virol 75:2194-2203;2001.
18. Fackler OT, d'Aloja P, Baur AS, Federico M, Peterlin BM. Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity. J Virol 75:6601-6608;2001.
19. Grzesiek S, Stahl SJ, Wingfield PT, Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35:10256-10261;1996.
20. Hahn T, Ahmad N. Genetic characterization of HIV type 1 gag p17 matrix genes in isolates from infected mothers lacking perinatal transmission. AIDS Res Hum Retroviruses 17:1673-1680;2001.
21. Hahn T, Matala E, Chappey C, Ahmad N. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission. AIDS Res Hum Retroviruses 15:875-888;1999.
22. Huang Y, Zhang L, Ho DD. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 69:93-100;1995.
23. Huelsenbeck JP, Crandall KA. Phylogeny estimation and hypothesis testing using maximum likelihood. Annu Rev Ecol Syst 28:437-466;1997.
24. Hughes AL, Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335:167-170;1988.
25. Husain M, Hahn T, Yedavalli VR, Ahmad N. Characterization of HIV type 1 tat sequences associated with perinatal transmission. AIDS Res Hum Retroviruses 17:765-773;2001.
26. Iafrate AJ, Bronson S, Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16:673-684;1997.
27. Ina Y. New methods for estimating the numbers of synonymous and nonsynonymous substitutions. J Mol Evol 40:190-226;1995.
28. Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662;1991.
29. Kim YH, Chang SH, Kwon JH, Rhee SS. HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: Dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes. Virology 257:208-219;1999.
30. Korber BT, Walker BD, Brander C, Koup R, Moore JP, Hayes BF, D'Souza PM, Myers G. In: HIV Molecular Immunology Database, Los Alamos National Laboratory, 1996.
31. Kuiken CL, Foley B, Guzman E, Korber BT, Crandall KA. In: The Evolution of HIV. Baltimore, The John Hopkins University Press, 432-468;1999.
32. Lama J, Mangasarian A, Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 9:622-631;1999.
33. Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85:931-942;1996.
34. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard JM, Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8:483-495;1998.
35. Liu SL, Schacker T, Musey L, Shriner D, McElrath MJ, Corey L, Mullins JI. Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses. J Virol 71:4284-4295;1997.
36. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier JL, Trono D. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6:67-77;1997.
37. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73:1964-1973;1999.
38. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 70:7752-7764;1996.
39. Matala E, Hahn T, Yedavalli VR, Ahmad N. Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res Hum Retroviruses 17:1725-1735;2001.
40. Mayaux M-J, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, Allemon M-C, Vilmer E, Vigneron NC, Tricoire J, Guillot F, Courpotin C. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 8:188-194;1995.
41. Mulder-Kampinga GA, Simonon GA, Kuiken CL, Dekker J, Scherpbier HJ, van de Perre P, Boer K, Goudsmit J. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mothers and infants is unrelated to time of HIV-1 RNA positivity in the child. J Virol 69:2285-2296;1995.
42. Myers G, Korber B, Foley B, Jeang K-T, Mellors JW, Wain-Hobson S: Theoretical Biology. Los Alamos, Los Alamos National Laboratory, 1996.
43. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418-426;1986.
44. Neiderman TM, Hastings WR, Ratner L. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci USA 86:1128-1132;1989.
45. Nielsen R, Yang Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936;1998.
46. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier JL, Trono D. Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97:63-73;1999.
47. Pitt J, Brambilla D, Reichelderfer P, Landay A, McIntosh K, Burns D, Hillyer GV, Mendez H, Fowler MG. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study. J Infect Dis 175:567-575;1997.
48. Posada D, Crandall KA. MODELTEST: Testing the model of DNA substitution. Bioinformatics 14:817-818;1998.
49. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, Bangham CR, Phillips RE. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 94:1890-1895;1997.
50. Ross TM, Oran AE, Cullen BR. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 9:613-621;1999.
51. Saksela K, Cheng G, Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14:484-491;1995.
52. Salvatori F, Scarlatti G. HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res Hum Retroviruses 17:925-935;2001.
53. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocom-patibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342;1996.
54. Shaheduzzaman S, Krishnan V, Petrovic A, Bittner M, Meltzer P, Trent J, Venkatesan S, Zeichner S. Effects of HIV-1 Nef on cellular gene expression profiles. J Biomed Sci 9:82-96;2002.
55. Sharp PM. In search of molecular darwinism. Nature 385:111-112;1997.
56. Sperling RS, Shapiro DE, Coombs RW. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 335:1621-1629;1996.
57. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5:997-103;1999.
58. Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony and Other Methods. Sunderland, Sinauer Associates, 1999.
59. The European Collaborative Study Group, Newell ML, Dunn DT, Peckham CS. Semprini A. E, Pardi G. Vertical transmission of HIV-1: Maternal immune status and obstetric factors. The European Collaborative Study. Aids 10:1675-1681;1996.
60. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 24:4876-4882;1997.
61. Vasco DA, Crandall KA, Fu Y-X, Rodrigo AG, Learn GH Jr. In: Computational and Evolutionary Analysis of HIV Molecular Sequences. Dordrecht, Kluwer Academic, 173-216;2001.
62. Welker R, Harris M, Cardel B, Krausslich HG. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: Analysis of its role in enhancement of viral infectivity. J Virol 72:8833-8840;1998.
63. Wilson CC, Brown RC, Korber BT, Wilkes BM, Ruhl DJ, Sakamoto D, Kunstman K, Luzuriaga K, Hanson IC, Widmayer SM, Wiznia A, Clapp S, Ammann AJ, Koup RA, Wolinsky SM, Walker BD. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: The ariel project for the prevention of transmission of HIV from mother to infant. J Virol 73:3975-3985;1999.
64. Wolfs TFW, Zwart G, Bakker M, Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189:103-110;1992.
65. Wolinsky S, Wike CM, Korber BTM, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munzo IL. Selective transmission of human immunodeficiency virus type-1 variants from mother to infants. Science 255:1134-1137;1992.
66. Yang Z: Phylogenetic Analysis by Maximum Likelihood (PAML), version 3.0. London, University College London, 2000 (http://abacus.gene.ucl.ac.uk/software/paml.html).
67. Yedavalli VRK, Ahmad N. Low conservation of HIV-1 type 1 vif and vpr genes correlates with lack of vertical transmission. AIDS Res Hum Retroviruses 17:911-923;2001.
68. Yedavalli VRK, Chappey C, Ahmad N. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J Virol 72:6937-6943; 1998.
69. Yedavalli VRK, Chappey C, Matala E, Ahmad N. Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission. J Virol 72:1092-1102;1998.
70. Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, Brunak S, Chigaev A, Detours V, Korber BT. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 76:8757-8768;2002.
71. Zanotto PM, Kallas EG, de Souza RF, Holmes EC. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153:1077-1089;1999.
72. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181;1993.